Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 2/20 | 0.53 |
| ▸ | FABP4 | P15090 | 1/20 | 0.53 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.53 |
| ▸ | CDK2 | P24941 | 1/20 | 0.53 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.53 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.51 |
| ▸ | SNCA | P37840 | 2/20 | 0.38 |
| ▸ | CHAT | P28329 | 1/20 | 0.38 |
| ▸ | ATIC | P31939 | 2/20 | 0.38 |
| ▸ | CD40 | P25942 | 2/20 | 0.37 |
| ▸ | CD40LG | P29965 | 2/20 | 0.37 |
| ▸ | F2 | P00734 | 1/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.37 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CES2 | O00748 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1742117 | 0.87 | TTR (0.59) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL1808443 | 0.81 | CA2 (0.55) | CDK2ATICF2PRSS1PRSS2 | |
| SCHEMBL11150678 | 0.80 | ALDH1A1 (0.43) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL465006 | 0.79 | CDK2 (0.53) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL8927875 | 0.79 | TTR (0.49) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL153141 | 0.78 | MAPT (0.57) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL179823 | 0.78 | TTR (0.58) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL10598159 | 0.78 | TTR (0.51) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL343611 | 0.78 | TTR (0.51) | TTRFABP4CCNA2CDK2MAPK14 | |
| SCHEMBL7744816 | 0.78 | TTR (0.51) | TTRFABP4CCNA2CDK2MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8404036-B2 | Water-soluble near-infrared absorbing coloring matters and aqueous inks containing same | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2013-03-26 | — | — | US | disclosed |
| US-20110123784-A1 | WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 2011-05-26 | — | — | US | disclosed |
| EP-0012411-B1 | ANTHRAQUINONE REACTIVE DYESTUFFS AND THEIR USE IN DYEING MATERIALS THAT CONTAIN HYDROXYL OR AMIDE GROUPS | BAYER AG (DE) | 1983-05-18 | — | — | EP | disclosed |
| US-4377688-A | Anthraquinone reactive dyestuffs, their preparation and their use for dyeing materials containing OH groups or amide groups | BAYER AKTIENGESELLSCHAFT (DE) | 1983-03-22 | — | — | US | disclosed |
| EP-0012411-A1 | Anthraquinone reactive dyestuffs and their use in dyeing materials that contain hydroxyl or amide groups | BAYER AG (DE) | 1980-06-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110123784-A1 | WATER-SOLUBLE NEAR-INFRARED ABSORBING COLORING MATTERS AND AQUEOUS INKS CONTAINING SAME | IK, RB1, COL1A1 | TTR 594/4885FABP4 4636/4885CCNA2 168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.